$VKTX
Market closedViking Therapeutics, Inc. · NasdaqCM
$25.36
▲ $0.47 (1.89%)
Open
$24.69
Prev close
$24.89
Day range
$24.42 – $25.41
Volume
4.15M
Avg volume
4.66M
Market cap
$3.22B
P/E (TTM)
—
Forward P/E
-5.84
EPS (TTM)
-4.76
52wk change
-28.00%
1M performance
-23.22%$33.03 → $25.36
Latest news
Viking (VKTX) Q3 2026 Earnings Call Transcript
Motley Fool · 26m ago
VKTX Stock Slides Overnight After Q3 Loss: CEO’s Obesity Drug Launch Timeline Frustrates Retail
Stocktwits · 2h ago
Viking Therapeutics falls on third quarter loss miss
Investing.com · 6h ago
Viking Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · 8h ago
Inventiva (IVA) vs. CRSP and MDGL: Can Lanifibranor’s Phase 3 Trial Unlock 62% Upside?
Insider Monkey · 15h ago
Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
Zacks · 1d ago
What moved $VKTX before
Logged catalysts for this stock, with the price reaction measured from real closes.
| Date | Factor | What happened | Next day | 1 week | 1 month | vs S&P |
|---|---|---|---|---|---|---|
| Feb 27, 2024 | 🧪 Clinical trial results | Phase 2 obesity data far exceeded expectations Single-asset biotech: the whole company revalued on one readout. | +121.02% | +137.37% | +110.06% | +120.84% |
Predictions on $VKTX
Make a call →Discussions on $VKTX
Start one →Market data from Yahoo Finance. Prices may be delayed. Not financial advice.